Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jun 17, 2021 12:29pm
66 Views
Post# 33404740

RE:RE:Another article on LMNL if u missed it

RE:RE:Another article on LMNL if u missed itNewcamo/ Realstocky (same guy behind both boardnames), irretrievably dumb. No posters here are on the bids while share price drops everyday. Do you really think you're creating hype on a deal with Kedrion that didn't close and a failed Phase 1 MAD study which knocked out Liminal's top prospects of 4050/fez in IPF and hypertryglycemedia indications. They know the bio marker indications on heart, liver and kidney and skin but they have said nothing so nothing of material value, right? Or else they would publish, right? This management team is either cr(l)iminal or just horrible performers. I think they're a bit of both. What do you think? Just fantastic and ready to execute with $100M with the same results as the last $500M over the past 4 years? 
<< Previous
Bullboard Posts
Next >>